Generic name: ESTROGENS, ESTERIFIED 1.25mg, METHYLTESTOSTERONE 2.5mg
Dosage form: tablet, coated
Medically reviewed on February 26, 2018.
Given cyclically for short-term use only
For treatment of moderate to severe vasomotor symptoms associated with the menopause in patients not improved by estrogen alone. The lowest dose that will control symptoms should be chosen and medication should be discontinued as promptly as possible. Administration should be cyclic (e.g., three weeks on and one week off). Attempts to discontinue or taper medication should be made at three to six month intervals.
Usual Dosage Range
1 capsule-shaped tablet of COVARYX® (1.25 mg/2.5 mg) or 1 to 2 capsule shaped tablets of COVARYX® H.S. (0.625 mg/1.25 mg) daily as recommended by the physician. Treated patients with an intact uterus should be monitored closely for signs of endometrial cancer and appropriate diagnostic measures should be taken to rule out malignancy in the event of persistent or recurring abnormal vaginal bleeding.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Covaryx (esterified estrogens / methyltestosterone)
- Covaryx Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: sex hormone combinations